These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 28780933)

  • 1. γδ T Cells: Unexpected Regulators of Cancer Development and Progression.
    Fleming C; Morrissey S; Cai Y; Yan J
    Trends Cancer; 2017 Aug; 3(8):561-570. PubMed ID: 28780933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
    Li Y; Li G; Zhang J; Wu X; Chen X
    Front Immunol; 2020; 11():619954. PubMed ID: 33664732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceleration of pancreatic tumorigenesis under immunosuppressive microenvironment induced by Reg3g overexpression.
    Liu X; Zhou Z; Cheng Q; Wang H; Cao H; Xu Q; Tuo Y; Jiang L; Zou Y; Ren H; Xiang M
    Cell Death Dis; 2017 Sep; 8(9):e3033. PubMed ID: 28880262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity.
    Lopes N; Silva-Santos B
    Eur J Immunol; 2021 Jan; 51(1):17-26. PubMed ID: 33188652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
    Wang H; Franco F; Ho PC
    Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking senescence and tolerogenic function of dendritic cells induced by γδ Treg cells enhances tumor-specific immunity for cancer immunotherapy.
    Si F; Liu X; Tao Y; Zhang Y; Ma F; Hsueh EC; Puram SV; Peng G
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: γδ T Cells in Cancer.
    Coffelt SB; Kabelitz D; Silva-Santos B; Kuball J; Born W; Bank I
    Front Immunol; 2020; 11():602411. PubMed ID: 33329597
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.
    Ye J; Ma C; Hsueh EC; Eickhoff CS; Zhang Y; Varvares MA; Hoft DF; Peng G
    J Immunol; 2013 Mar; 190(5):2403-14. PubMed ID: 23355732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy.
    Van Acker HH; Campillo-Davo D; Roex G; Versteven M; Smits EL; Van Tendeloo VF
    Cytokine Growth Factor Rev; 2018 Jun; 41():54-64. PubMed ID: 29773448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. γδ T cells and the PD-1/PD-L1 axis: a love-hate relationship in the tumor microenvironment.
    Liu J; Wu M; Yang Y; Wang Z; He S; Tian X; Wang H
    J Transl Med; 2024 Jun; 22(1):553. PubMed ID: 38858763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
    Guo Z; Wang H; Meng F; Li J; Zhang S
    J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLA2G4A promotes right-sided colorectal cancer progression by inducing CD39+γδ Treg polarization.
    Zhan Y; Zheng L; Liu J; Hu D; Wang J; Liu K; Guo J; Zhang T; Kong D
    JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34283812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Effects of γδ T Cells in Colorectal Cancer: A Review.
    Ma R; Yuan D; Guo Y; Yan R; Li K
    Front Immunol; 2020; 11():1600. PubMed ID: 33013819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γδ cell-based immunotherapy for cancer.
    Lo Presti E; Corsale AM; Dieli F; Meraviglia S
    Expert Opin Biol Ther; 2019 Sep; 19(9):887-895. PubMed ID: 31220420
    [No Abstract]   [Full Text] [Related]  

  • 15. The paradox of Th17 cell functions in tumor immunity.
    Asadzadeh Z; Mohammadi H; Safarzadeh E; Hemmatzadeh M; Mahdian-Shakib A; Jadidi-Niaragh F; Azizi G; Baradaran B
    Cell Immunol; 2017 Dec; 322():15-25. PubMed ID: 29103586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor hypoxia represses γδ T cell-mediated antitumor immunity against brain tumors.
    Park JH; Kim HJ; Kim CW; Kim HC; Jung Y; Lee HS; Lee Y; Ju YS; Oh JE; Park SH; Lee JH; Lee SK; Lee HK
    Nat Immunol; 2021 Mar; 22(3):336-346. PubMed ID: 33574616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T Cells Tailored with pH-Responsive Liposomes Shape an Immuno-Antitumor Milieu against Tumors.
    Ou W; Jiang L; Gu Y; Soe ZC; Kim BK; Gautam M; Poudel K; Pham LM; Phung CD; Chang JH; Kim JR; Ku SK; Yong CS; Kim JO
    ACS Appl Mater Interfaces; 2019 Oct; 11(40):36333-36346. PubMed ID: 31535550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γδ T cells in cancer immunotherapy.
    Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
    Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.
    Chew V; Lai L; Pan L; Lim CJ; Li J; Ong R; Chua C; Leong JY; Lim KH; Toh HC; Lee SY; Chan CY; Goh BKP; Chung A; Chow PKH; Albani S
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5900-E5909. PubMed ID: 28674001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy.
    Takeda Y; Kataoka K; Yamagishi J; Ogawa S; Seya T; Matsumoto M
    Cell Rep; 2017 May; 19(9):1874-1887. PubMed ID: 28564605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.